KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Times Interest Earned (2017 - 2026)

Aquestive Therapeutics has reported Times Interest Earned over the past 9 years, most recently at -$10.38 for Q4 2025.

  • For Q4 2025, Times Interest Earned fell 112.46% year-over-year to -$10.38; the TTM value through Dec 2025 reached -$6.39, down 130.94%, while the annual FY2025 figure was -$6.39, 130.94% down from the prior year.
  • Times Interest Earned for Q4 2025 was -$10.38 at Aquestive Therapeutics, down from -$4.13 in the prior quarter.
  • Over five years, Times Interest Earned peaked at $0.02 in Q2 2024 and troughed at -$10.38 in Q4 2025.
  • A 5-year average of -$4.36 and a median of -$3.65 in 2024 define the central range for Times Interest Earned.
  • Biggest five-year swings in Times Interest Earned: soared 100.65% in 2024 and later plummeted 20754.23% in 2025.
  • Year by year, Times Interest Earned stood at -$6.69 in 2021, then grew by 2.96% to -$6.49 in 2022, then surged by 73.5% to -$1.72 in 2023, then plummeted by 183.98% to -$4.89 in 2024, then crashed by 112.46% to -$10.38 in 2025.
  • Business Quant data shows Times Interest Earned for AQST at -$10.38 in Q4 2025, -$4.13 in Q3 2025, and -$4.09 in Q2 2025.